Cutler Group LP Alaunos Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	BUY	$1.04 - $322.5 $2,288 - $709,500	2,200 New	2,200 $0
Q1 2018 May 11, 2018	SELL	$3.46 - $5.14 $14,878 - $22,102	-4,300 Reduced 87.76%	600 $0
Q4 2017 Jan 17, 2018	SELL	$4.0 - $6.54 $5,600 - $9,156	-1,400 Reduced 22.22%	4,900 $0
Q3 2017 Oct 17, 2017	BUY	$4.99 - $6.57 $31,437 - $41,391	6,300	6,300 $2,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.